 |  |
KICKING CANCER: It's one of the most crucial meetings for healthcare. Mike Huckman is live from the annual meeting of the American Society of Clinical Oncology, and in rare fashion, lung cancer drugs and studies are expected to be front and center. While ASCO released the bulk of the data a couple weeks ago online, the most promising, headline-making data is held back from release until the conference itself.
| THE FACE OF PFIZER'S CANCER VACCINE: He's dying of brain cancer. But he's in a clinical trial for a brain cancer "vaccine" owned by a company that Pfizer just bought for $200M with fresh data coming out at ASCO. Pfizer is trying to get a bigger footprint in oncology, recently creating a separate division for it and hiring someone from Eli Lilly to run it. This is a therapeutic vaccine which you get after you get the cancer, and Bobby Murcer is counting on the company to help him with a miracle, and investors are rooting him along.
| JANE ON THE TRAIN: While Los Angeles is the nation's second biggest city, its mass transit system is considerably underused. But because of the rising price of fuel, ridership has jumped a surprising 15%. This in the town where people drive to go across the street! Monday morning, Jane Wells ditches her car for the train for her 75 mile daily roundtrip commute, that now costs about $15/day in gas. Is it cheaper to take the train? It's not faster for Jane who doesn't drive during rush hour-- though it would be faster for those who do.
| INTERNATIONAL PROFITS: One of the hardest hit industries in the face of rising fuel costs is undeniably the airline sector. Measures have been announced to cut costs and raise revenues across the board, from charging for checked baggage to increasing fuel surcharges. But what's being done to add to profit? Some think the answer lies overseas. Delta is set to announce eight new international destinations, and Legacy airlines will try to increase profits by adding new routes to cities in areas previously untapped (like Africa!). Phil LeBeau explores the newest international expansion strategy and asks: is anything enough to save this struggling sector?
|
| | |
No comments:
Post a Comment